Buy Rating Affirmed for Plus Therapeutics Amidst ReSPECT-GBM Trial Progress and Overlooked Market Potential
In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...
Buy Rating Justified: Anticipated 30% Stock Upside and Improved Margins for Grab
Analyst Divya Gangahar from Morgan Stanley maintained a Buy rating on Grab (GRAB – Research Report) and increased the price target to ...
3 ASX shares to buy and 1 to sell: brokers
Brokers are forecasting these ASX shares could gain 7% to 17% in the months ahead. The post 3 ASX shares to buy and 1 to sell: brokers appeared first on The Motley Fool Australia.
Why Collins Foods, MacMahon, Mirvac, and Sigma shares are pushing higher today
Why are investors bidding these shares higher today? Let's find out. The post Why Collins Foods, MacMahon, Mirvac, and Sigma ...
Long Islanders face serious financial threat from flooding, report finds
More than 530,000 Long Islanders live in properties at serious risk of flooding, according to new estimates published ...